Sarcomatrix Therapeutics To Present Advances In Muscle Disease Drug Development At 2025 BIO CEO & Investor Conference
Sarcomatrix Therapeutics, Corp Logo Company Prepares for Phase 1 Clinical Trials of Lead Candidate S-969 in 2025 Our robust preclin ...
Drugmaker to study pig kidney transplants in humans with groundbreaking trial
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
New Hampshire man is 2nd person known to be living with a pig kidney
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from dialysis, Massachusetts General Hospital announced Friday, and recovering so ...
US government warns users to patch this critical Microsoft Outlook bug
CISA adds an Outlook improper input validation bug to KEV The deadline to patch is February 27 2025 Criminals are using it for remote code execution The US Cybersecurity and Infrastructure Security ...
United States Solar Photovoltaic (PV) Market Outlook to 2035, with Profiles of WEC Energy Group, The AES Corp, Santee Cooper, PPL Corp and NRG Energy
The "US Solar Photovoltaic (PV) Analysis: Market Outlook to 2035, Update 2024" report has been added to ResearchAndMarkets.com's offering.The report offers comprehensive information and an ...
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
United States Hydropower Market Outlook to 2035, with Competitor Analysis of WEC Energy Group, The AES Corp, Santee Cooper, PPL Corp and GE Vernova
The "US Hydropower Analysis: Market Outlook to 2035, Update 2024" report has been added to ResearchAndMarkets.com's offering.The report offers comprehensive information and understanding of the ...
United Therapeutics price target lowered to $460 from $475 at UBS
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
United Therapeutics president sells $3.5m in stock
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
Le Lézard3d
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
On February 3rd, our Board of Directors approved another tax-efficient share repurchase program of up to 10% of our total shares outstanding, expected to be executed over the next three to six months.
United Therapeutics Says FDA Clears IND For The UKidney Xenotransplantation Clinical Trial
United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...
Le Lézard4d
Nova Completes Acquisition of Sentronics
Nova  announced today that it completed the acquisition of Sentronics Metrology GmbH, a privately held company headquartered in Germany. The transaction is valued at approximately $60 million, paid in ...